Clinical Trials Directory

Trials / Unknown

UnknownNCT02861209

Collaborative Network to Take Responsibility for Oral Anticancer Therapy

CONTACT: A Prospective Interventional Multicentre Before-after Study for the Implementation of a Care Pathway to Increase Self-management of Patients With Cancer Who Are Treated With Oral Anticancer Medications

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
228 (estimated)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to develop, implement and evaluate a care pathway for patients with cancer who are treated with oral anticancer drugs (OACD). The care pathway will be developed in six hospitals in Flanders, and will be adapted to the local setting and situation. The investigators hypothesize that the implementation of a care pathway will increase the quality of the drug therapy, the communication between health care professionals (HCPs) and patients, and will lead to an improved level of self-management and adherence. Moreover, the invesitgators hypothesize that the care pathway will facilitate the communication between HCPs in the hospital setting and in ambulatory care, and will improve counseling skills, self-efficacy and self-confidence of HCPs. At the end of the study, a roadmap for the nation-wide implementation of a similar care pathway will be constructed based on the experiences of the participating hospitals. This roadmap will certainly include an e-learning platform for healthcare professionals.

Detailed description

For each hospital, an individual care pathway will be developed following the 7-phase model by Vanhaecht et al., 2011. This methodology aims to offer a systematic approach in 7 phases for the support of an interdisciplinary team in the development of new care pathways or in the improvement of existing ones. The before-part of the study includes phases 1 to 4 that aim to map current practice in detail and to translate these findings into the development of a care pathway. Current practice will be investigated using mixed methods comprising: * surveys evaluating care on the level of the hospital * semi-structured interviews with healthcare professionals (HCP) and patients * outcome assessments in patients included in the study (self-management, adherence, satisfaction with care, satisfaction with information, quality of life) using validated questionnaires at the start of the therapy, after 1 month and after three months * outcome assessments in healthcare professionals at baseline (self-efficacy and perceptions on self-management) using validated questionnaires * training and feedback sessions on counseling for HCPs Based upon these findings, a care pathway in each hospital will be developed by a local project team of different stakeholders from different disciplines. The after-part of the study includes phase 5-7 in which the care pathway is implemented, evaluated and continuously followed up. Implementation and evaluation take place at the same time. The evaluation includes: * outcome assessments in patients (newly recruited) at the start of the therapy, after 1 month and after three months * outcome assessments in HCPs (follow up) * evaluation of counseling skills * focus group discussions and interviews with HCPs to evaluate the development and implementation of the care pathway. At the end of the study a comparison of outcomes before and after the implementation will be made to study the impact of the care pathway on the before mentioned aspects (see "Brief Summary").

Conditions

Interventions

TypeNameDescription
OTHERImplementation of a care pathwayThe care pathway will consist of procedures of care in the hospital (e.g. consultations with doctors, contact moments with nurses, ...) that describe the initiation of an oral anticancer therapy and the further follow up. The care pathway should describe how care can efficiently be organised.

Timeline

Start date
2015-11-01
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2016-08-10
Last updated
2019-04-16

Locations

4 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02861209. Inclusion in this directory is not an endorsement.

Collaborative Network to Take Responsibility for Oral Anticancer Therapy (NCT02861209) · Clinical Trials Directory